Physician profile
Rafle Fernandez
NPI 1033451877
$6,882.56
in general payments reported to CMS, 2019-2025
23 companies · $2,699 in 2025
The $2,699 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,332 · 2020: $188 · 2021: $302 · 2022: $375 · 2023: $501 · 2024: $485 · 2025: $2,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,974 · Travel and Lodging: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,974.46 |
| Travel and Lodging | $711.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,781.00 | 2019-2023 | Mitraclip |
| Edwards Lifesciences Corporation | $1,547.41 | 2025 | Evoque |
| Boston Scientific Corporation | $602.73 | 2019-2025 | Watchman Flx, Farapulse |
| Heartflow, INC. | $443.55 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $291.43 | 2024-2025 | Opsumit, Uptravi |
| Pfizer INC. | $259.62 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $246.10 | 2019-2023 | Xarelto |
| Irhythm Technologies, INC. | $216.45 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $215.28 | 2019-2025 | Camzyos, Eliquis |
| Astellas Pharma US INC | $201.35 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $195.17 | 2019-2025 | Wainua |
| Zoll Circulation INC | $147.60 | 2023 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Medtronic, INC. | $147.59 | 2021 | |
| Medtronic Vascular, INC. | $127.09 | 2019 | |
| Novartis Pharmaceuticals Corporation | $123.97 | 2019-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $101.65 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.93 | 2019-2020 | |
| Axogen | $47.72 | 2025 | |
| Exact Sciences Corporation | $40.76 | 2023-2024 | Cologuard Collection Kit |
| Urovant Sciences INC | $22.15 | 2022 | |
| Ibsa Pharma INC. | $18.67 | 2023 | Tirosint, Licart |
| Hologic Sales and Service, LLC | $18.55 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafle Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.